Akèy › Kansè tiwoyid
Etid klinik pou Kansè tiwoyid ap rekrite nan Etazini
51 etid pou Kansè tiwoyid ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX12 etid
- Washington, DC10 etid
- New York City, NY9 etid
- Philadelphia, PA6 etid
- Boston, MA6 etid
- Nashville, TN5 etid
- Durham, NC5 etid
- Los Angeles, CA5 etid
- San Francisco, CA4 etid
- Ann Arbor, MI4 etid
- Minneapolis, MN4 etid
- Memphis, TN4 etid
- San Antonio, TX4 etid
- St. Louis, MO4 etid
- Akron, OH3 etid
- Cleveland, OH3 etid
- Baltimore, MD3 etid
- Highlands Ranch, CO3 etid
- Rochester, MN3 etid
- Baldwin Park, CA3 etid
- Aurora, CO3 etid
- Seattle, WA3 etid
Pa eta
- Arizona4 etid
- Colorado6 etid
- Connecticut3 etid
- Distrik Columbia5 etid
- Florid10 etid
- Georgia3 etid
- Illinois4 etid
- Indiana3 etid
- Kalifòni14 etid
- Kansas3 etid
- Maryland9 etid
- Massachusetts7 etid
- Michigan5 etid
- Minnesota7 etid
- Missouri5 etid
- New York10 etid
- North Carolina6 etid
- Ohio7 etid
- Pennsylvania7 etid
- Tennessee8 etid
- Texas15 etid
- Virginia4 etid
- Washington3 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT01247597DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01005654Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06507878The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Ap rekriteFaz 2
Laj 18 a 98 · Tout sèks · Mizajou Sep 16, 2026 · NCT04927416Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07218315Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT03647358The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Ap rekriteFaz 2
Laj 18 a 90 · Tout sèks · Mizajou Sep 9, 2026 · NCT03841617XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06902376Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06959511Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069Studies on Tumors of the Thyroid
Ap rekriteEtid obsèvasyon
6 Months – 98 Years · Tout sèks · Mizajou Aug 31, 2026 · NCT00001160A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT07225309Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT03099356Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Ap rekriteFaz 2
Laj 2 a 25 · Tout sèks · Mizajou Jul 24, 2026 · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Ap rekrite
Laj 21 a 45 · Tout sèks · Mizajou Jul 6, 2026 · NCT07406087Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jun 30, 2026 · NCT04892303Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT06007924Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Ap rekriteFaz 2
Laj 13 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT06961084Environmental Factors and Thyroid Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05172921Hereditary Risk Factors for Thyroid Cancer
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 11, 2026 · NCT02747888A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT04589624Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.